Quantcast
Last updated on April 19, 2014 at 9:20 EDT

Latest drug discovery Stories

2014-02-21 23:22:15

Markets Research Reports.biz added deep and professional market research reports on Global and China "Hyper Pigmentation Global Clinical Trials Review, H1, 2014" Market Analysis and Overview. Visit: http://www.marketresearchreports.biz/analysis/188577. Albany , NY (PRWEB) February 21, 2014 Hyper Pigmentation Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, Hyper Pigmentation Global Clinical Trials Review, H1, 2014" provides data on the...

2014-02-21 23:04:33

These funds were awarded as part of Families of SMA’s basic research grant program. Basic research looks into the causes of SMA, revealing new and better ways of making drugs to target the disease. Elk Grove Village, IL (PRWEB) February 21, 2014 Families of SMA has announced seven grants, totaling $600,000 in new funding, for research into the causes of Spinal Muscular Atrophy (SMA). SMA affects an estimated 1 in every 10,000 children, and is the number one genetic killer of children...

2014-02-21 23:00:39

MarketResearchReports.Biz includes new market research report "Cardiac Arrest Global Clinical Trials Review, H1, 2014" to its huge collection of research reports. (PRWEB) February 22, 2014 GlobalData's clinical trial report, "Cardiac Arrest Global Clinical Trials Review, H1, 2014" provides data on the Cardiac Arrest clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cardiac Arrest. It includes an overview...

2014-02-20 08:30:25

LONDON, Feb. 20, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Aortic Valve Diseases Global Clinical Trials Review, H2, 2013 Aortic Valve Diseases Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, "Aortic Valve Diseases Global Clinical Trials Review, H2, 2013" provides data on the Aortic Valve Diseases clinical trial scenario. This report provides elemental information and data relating to the clinical trials on...

2014-02-19 08:34:16

- Jeffrey Herpst joins Baltimore-based Gliknik Inc. to advance mid-stage clinical drug candidates in Gliknik's innovative immunomodulator program - BALTIMORE, Feb. 19, 2014 /PRNewswire/ -- Gliknik Inc., a privately held biopharmaceutical company, today announced that it has expanded its team by adding a new Senior Director of Clinical Development and electing two new members to its Board of Directors. Gliknik is deepening its clinical staff and allocating resources to further...

2014-02-19 04:22:21

Full Service CRO WCCT Global announces program for orphan drug development. COSTA MESA, Calif., Feb. 19, 2014 /PRNewswire-iReach/ -- WCCT Global, a multi-site full service CRO that is headquartered in Southern California announced today a specialized program to conduct clinical research for sponsors who are engaged in orphan drug development. Aside from the often referenced technical and commercial hurtles which must be overcome before deciding to launch the development program for...

2014-02-18 23:25:00

Collaboration will create methodologies to drive improved decision-making in exploratory phase development. Reston, Virginia (PRWEB) February 18, 2014 Aptiv Solutions, a global biopharmaceutical and medical device development services company leading the adoption of innovative clinical trial approaches such as adaptive design, today announced that Novartis Pharma AG, Janssen Pharmaceuticals Inc, and Eli Lilly have joined them in co-founding the ADDPLAN DF Consortium. The members of the...

2014-02-15 23:01:13

RnRMarketResearch.com adds “High Content Screening Market by Instruments (Cell Imaging and Analysis System), by Applications (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling), Software & Services – Global Forecasts to 2018” to its store. Dallas, Texas (PRWEB) February 15, 2014 The global high content screening market is a technology-driven market and is marked by the ‘Threat of Obsolescence,’ wherein technologies as...

2014-02-14 23:25:48

More and more frequently, pharma companies are sending their research into less experienced countries and regions. Noted clinical trial statistician Dr. Johan Karlberg has collected and analyzed 7 years of industry-sponsored clinical trial data to help identify which countries and regions are the best choices for hosting clinical trials now, as well as the long-term outlook for multiyear studies. Falls Church, VA (PRWEB) February 14, 2014 Globalization of Industry-Sponsored Clinical...

2014-02-14 23:21:13

MarketReportsOnline.com adds "US Orphan Drug Market Outlook 2018" report to its research store. Dallas, Texas (PRWEB) February 14, 2014 In the largest market for orphan drugs, USA, there was a shortage of adequate therapies for treating many rare diseases. These therapies were not developed as companies did not expect these drugs to be highly profitable. Hence there was a lack of interest and thus investment on the part of pharma companies in the USA. Therefore, the FDA...